PT  - JOURNAL ARTICLE
AU  - Jandric, Danka
AU  - Doshi, Anisha
AU  - Scott, Richelle
AU  - Paling, David
AU  - Rog, David
AU  - Chataway, Jeremy
AU  - Schoonheim, Menno
AU  - Parker, Geoff
AU  - Muhlert, Nils
TI  - A systematic review of resting state functional MRI connectivity changes and cognitive impairment in multiple sclerosis
AID  - 10.1101/2021.03.18.21253878
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.18.21253878
4099  - http://medrxiv.org/content/early/2021/03/20/2021.03.18.21253878.short
4100  - http://medrxiv.org/content/early/2021/03/20/2021.03.18.21253878.full
AB  - Cognitive impairment is common in multiple sclerosis (MS) and resting state functional MRI (rs-fMRI) functional connectivity (FC) is increasingly used to study its pathophysiology. However, results remain difficult to interpret, showing both high and low FC associated with cognitive impairment. We conducted a systematic review of rs-fMRI studies in MS to understand whether the direction of FC change relates to cognitive dysfunction, and how this may be influenced by the choice of methodology. Embase, Medline and PsycINFO were searched for studies assessing cognitive function and rs-fMRI FC in adults with MS. Fifty-seven studies were included in a narrative synthesis. Of these, 50 found an association between cognitive impairment and FC abnormalities. Worse cognition was linked to high FC in 18 studies, and to low FC in 17 studies. Nine studies found patterns of both high and low FC related to poor cognitive performance, in different regions or for different MR metrics. There was no clear link to increased FC during early stages of MS and reduced FC in later stages, as predicted by common models of MS pathology. Throughout, we found substantial heterogeneity in study methodology, and carefully consider how this may impact on the observed findings. These results indicate an urgent need for greater standardisation in the field – in the choice of MRI analysis and the definition of cognitive impairment. Through this we will be closer to using rs-fMRI FC as a biomarker in clinical studies, and as a tool to understand mechanisms underpinning cognitive symptoms in MS.Key pointsCognitive impairment in multiple sclerosis (MS) is increasingly being researched with advanced magnetic resonance imaging (MRI) measures, including resting state functional MRI (rs-fMRI)The rs-fMRI functional connectivity (FC) metric is associated with cognitive impairment, and has the potential to be a biomarker of cognitive decline.A main challenge to developing a FC biomarker is the lack of consistency in the direction of FC changes associated with cognitive impairment, with cognitive deficits associated with both lower and higher FC.FC changes don’t appear to be linked to clinical and methodological factors such as disease phenotype, disease duration and brain region or network studied.Overall, there is substantial heterogeneity in study methodology, suggesting an acute need to standardise the study of cognitive impairment in MS and its investigation by rs-fMRI methods.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by a grant held by DJ. DJ was supported by a Medical Research Council Doctoral Training Partnership grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/A, secondary data usedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAbbreviationsBICAMSBrief International Cognitive Assessment for Multiple SclerosisBMSBenign Multiple SclerosisBOLDBlood-Oxygenation-Level-DependentCICognitively ImpairedCISClinically Isolated SyndromeCPCognitively PreservedDMNDefault Mode NetworkEDSSExpanded Disability Status ScaleFCFunctional ConnectivityICAIndependent Component AnalysisMACFIMSMinimal Assessment of Cognitive Function in Multiple SclerosisMRIMagnetic Resonance ImagingMSMultiple SclerosisPASATPaced Auditory Serial Addition TestPPMSPrimary Progressive Multiple SclerosisPRISMAPreferred Reporting Items for Systematic Reviews and Meta-AnalysisPROSPEROInternational Prospective Register of Systematic ReviewsROIRegion Of InterestRRMSRelapsing-Remitting Multiple SclerosisRs-fMRIResting State Functional MRIRSNResting State NetworkSCASeed Based Connectivity AnalysisSDMTSymbol Digit Modalities TestSPMSSecondary Progressive Multiple Sclerosis